Trial Profile
A trial of maraviroc for the treatment of patients with HIV-1 infection- The European Coreceptor (EUCO) HIV Cohort Study
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 06 Dec 2017
Price :
$35
*
At a glance
- Drugs Maraviroc (Primary)
- Indications HIV-1 infections
- Focus Therapeutic Use
- 27 Oct 2017 Results presented at the 16th European AIDS Conference
- 01 Mar 2016 New trial record